We are live on ! Find out more
RHBC

R.H. Bluestein & Co Portfolio holdings

AUM $1.61B
1-Year Est. Return 7.59%
This Fund
S&P 500
This Quarter Est. Return
+8.28%
1 Year Est. Return
-7.59%
3 Year Est. Return
+69.02%
5 Year Est. Return
+139.59%
10 Year Est. Return
–
AUM
$1.6B
AUM Growth
+$193M
Cap. Flow
+$93M
Cap. Flow %
5.81%
Top 10 Hldgs %
31.99%
Holding
319
New
17
Increased
57
Reduced
60
Closed
28

Top Buys

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$21.7M
2
RTN
Raytheon Company
RTN
+$19.1M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$12.9M
4
EA icon
Electronic Arts
EA
+$10.2M
5
IBM icon
IBM
IBM
+$7.99M

Top Sells

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$18.2M
2
JNJ icon
Johnson & Johnson
JNJ
+$17.9M
3
WLL
Whiting Petroleum Corporation
WLL
+$16.9M
4
CVS icon
CVS Health
CVS
+$5.58M
5
PSX icon
Phillips 66
PSX
+$5.21M

Sector Composition

Rank Sector Weight
1 Industrials 19.98%
2 Consumer Discretionary 14.39%
3 Communication Services 12.39%
4 Healthcare 10.96%
5 Materials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.A icon
51
Berkshire Hathaway Class A
BRK.A
$1.1T
$1.98M 0.12%
10
– –
JNJ icon
52
Johnson & Johnson
JNJ
$617B
$1.93M 0.12%
18,820
-178,254
-90% -$17.9M
SDS icon
53
ProShares UltraShort S&P500
SDS
$420M
$1.79M 0.11%
899
-111
-11% -$223K
CHKP icon
54
Check Point Software Technologies
CHKP
$13.1B
$1.72M 0.11%
21,190
-10
-0% -$829
ALV icon
55
Autoliv
ALV
$9.09B
$1.68M 0.11%
18,738
– –
TNXP icon
56
Tonix Pharmaceuticals
TNXP
$161M
– –
0
– –
PFE icon
57
Pfizer
PFE
$142B
$1.62M 0.1%
52,756
+31,960
+154% +$1.01M
UN
58
DELISTED
Unilever NV New York Registry Shares
UN
$1.52M 0.09%
35,000
– –
NVO
59
Novo Nordisk
NVO
$228B
$1.45M 0.09%
50,000
-50
-0.1% -$1.38K
STLA icon
60
Stellantis
STLA
$17B
$1.4M 0.09%
153,371
– –
GLOG
61
DELISTED
GASLOG LTD
GLOG
$1.38M 0.09%
166,450
-6,610
-4% -$71K
CNI icon
62
Canadian National Railway
CNI
$76.9B
$1.34M 0.08%
24,000
– –
TEVA icon
63
Teva Pharmaceuticals
TEVA
$41.2B
$1.31M 0.08%
20,000
– –
NVS icon
64
Novartis
NVS
$301B
$1.31M 0.08%
16,963
– –
LUX
65
DELISTED
Luxottica Group
LUX
$1.3M 0.08%
20,003
– –
BUD icon
66
AB InBev
BUD
$166B
$1.27M 0.08%
10,125
-100
-1% -$12.1K
TM icon
67
Toyota
TM
$227B
$1.23M 0.08%
10,000
– –
RDY icon
68
Dr. Reddy's Laboratories
RDY
$9.85B
$1.2M 0.08%
130,000
– –
TSM icon
69
TSMC
TSM
$2.09T
$1.14M 0.07%
50,053
– –
DEO icon
70
Diageo
DEO
$49.5B
$1.09M 0.07%
10,000
-5
-0% -$564
SNN icon
71
Smith & Nephew
SNN
$13.6B
$1.07M 0.07%
30,000
– –
DXCM icon
72
DexCom
DXCM
$28.8B
$1.06M 0.07%
52,000
-6,000
-10% -$125K
AXON
73
Axon Enterprise
AXON
$42.3B
$1.06M 0.07%
61,100
+45,240
+285% +$906K
BIDU icon
74
Baidu
BIDU
$36.5B
$1.04M 0.07%
5,500
– –
TTM
75
DELISTED
Tata Motors Limited
TTM
$1.03M 0.06%
35,000
– –
1 2
3
4 5

Similar funds

BDF
Balasa Dinverno & Foltz $1.58B AUM 17.55% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
WFA
Wipfli Financial Advisors Milwaukee, Wisconsin $1.42B AUM 20.63% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
CA
Capitolis Advisors New York $1.41B AUM 17.33% 1-Year Est. Return
RIG
Roosevelt Investment Group New York $1.39B AUM 5.42% 1-Year Est. Return
CCP
Corient Capital Partners Newport Beach, California $1.34B AUM 12.46% 1-Year Est. Return

R.H. Bluestein & Co's Q4 2015 Portfolio in Review

As of Q4 2015, R.H. Bluestein & Co held 319 positions worth $1.6B, up 14% from $1.41B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

R.H. Bluestein & Co deployed $93M of net new capital in Q4 2015, opening 17 new positions and adding to 57 existing holdings. Its largest new stake was ConocoPhillips: 69,600 shares worth $3.25M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was SLB Ltd, an estimated $18.2M trimmed.

  • R.H. Bluestein & Co's largest Q4 2015 buy was ConocoPhillips: 69,600 shares worth $3.25M.
  • R.H. Bluestein & Co added most to GE Aerospace in Q4 2015, an estimated $21.7M increase.
  • R.H. Bluestein & Co's biggest Q4 2015 reduction was SLB Ltd, cutting an estimated $18.2M.
  • R.H. Bluestein & Co fully exited Oracle in Q4 2015, selling an estimated $1.65M.
  • R.H. Bluestein & Co's ten largest holdings make up 32% of its $1.6B portfolio in Q4 2015.
  • R.H. Bluestein & Co opened 17 new positions and closed 28 in Q4 2015.
  • R.H. Bluestein & Co's portfolio value rose 14% quarter-over-quarter to $1.6B.

Based on R.H. Bluestein & Co's 13F filing for Q4 2015, filed 12 Feb 2016.